Research for Individualized Therapeutics in Rare Genetic Disease

Undiagnosed Diseases Clinical Trial

Official title:
Research for Individualized Therapeutics in Rare Genetic Disease

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this research study is to identify individuals that have a rare genetic disease without an adequate therapeutic strategy that might be treatable with drug developed to target the disease-causing genetic alteration.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05236595
Study type	Observational [Patient Registry]
Source	Mayo Clinic
Contact
Status	Enrolling by invitation
Phase
Start date	November 24, 2021
Completion date	November 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05007990` - Caregiving Networks Across Disease Context and the Life Course
Recruiting	`NCT02543996` - Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
Terminated	`NCT05295758` - Project 1: ACHIEVE- HTN	N/A
Active, not recruiting	`NCT06261944` - A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package	N/A